Abilify
Product Images NDC 16590-323

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Abilify (NDC 16590-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abilify 2mg Label (Abilify 2mg Label)

Packaging label for Abilify 2 mg tablets, containing 30 tablets. The label indicates the active ingredient as aripiprazole 2 mg per tablet. It is distributed by STAT RX USA LLC, Gainesville, GA, and manufactured by Otsuka America Pharma Inc, Rockville, MD. The label includes storage instructions and warnings about the risk of dizziness and operating dangerous machinery.*

FDA Label Image

Label Image (Abilify 5mg Label 745)

Label for ABILIFY 5 mg tablets, packaged and distributed by STAT RX USA LLC. The label indicates the product contains 60 tablets, each with 5 mg of the active ingredient aripiprazole. It is a generic product manufactured by Bristol-Myers Squibb Co., Princeton, NJ. The label includes an NDC number 16590-745-60 and standard cautionary and storage instructions.*

FDA Label Image

Aripiprazole Chemical Structure (Abilify Structure)

Chemical structure diagram of the active ingredient in ABILIFY, showing atomic connectivity including chlorine atoms and a nitrogen-containing ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.